Accelerated approval mandates ctDNA-confirmed ESR1 mutation emergence during ongoing AI+CDK4/6 therapy, prompting AI replacement with camizestrant while maintaining abemaciclib, palbociclib, or ...
WASHINGTON, DC – The U.S. Food and Drug Administration (FDA) has approved the country’s first mRNA-based influenza vaccine, developed by Moderna. The vaccine is approved for adults aged 50 to 64 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results